Two Phase 3 Trials of Dupilumab versus Placebo in Atopic DermatitisEric L. Simpson, Marius Ardeleanu, Thomas Bieber et al.|New England Journal of Medicine|2016Cited by 2k
Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trialDiamant Thaçi, Marius Ardeleanu, Eric L. Simpson et al.|The Lancet|2015Cited by 566
Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic DermatitisEric L. Simpson, Ashish Bansal, Bolanle Akinlade et al.|JAMA Dermatology|2019Cited by 505
Efficacy of Dupilumab in a Phase 2 Randomized Trial of Adults With Active Eosinophilic EsophagitisIkuo Hirano, Allen Radin, Evan S. Dellon et al.|Gastroenterology|2019Cited by 448
Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: A randomized, double-blinded, placebo-controlled phase 3 trialAmy S. Paller, Brad Shumel, Elaine C. Siegfried et al.|Journal of the American Academy of Dermatology|2020Cited by 385